5338 Live Notices for Germany Pharmaceutical Products Tenders
Showing 1 to 20
Openhouse Methods Various Drug Active Ingredients From 01.10.2025
24 May 2025
31 Dec 2027Open House Original Discount Contracts 2025-16 - Empagliflozin
Care Of Autodesk Products (25-33095)
Open-House-Drug Discount Contracts In Accordance With Section 130A (8C) Sgb V For The Kv-Region Berlin
Open-House Drug Discount Contracts In Accordance With Section 130A (8C) Sgb V For The Kv Region Brandenburg
Open-House Drug Discount Contracts In Accordance With Section 130A (8C) Sgb V For The Kv Region Mecklenburg-Western Pomerania
Open-House Drug Discount Contracts In Accordance With Section 130A (8C) Sgb V For The Kv Region Mecklenburg-Western Pomerania
Open House Original Discount Contracts 2025-17 - Beclometason, Formoterol, Glycopyrronium (Combination Of Active Ingredients) Atc: R03Al09
Open-House Drug Discount Contracts In Accordance With Section 130A (8C) Sgb V For The Kv Region Brandenburg
Open-House-Drug Discount Contracts In Accordance With Section 130A (8C) Sgb V For The Kv-Region Berlin
Zaw - Merchant For Forwarding And Logistics Service - Aachen | Ml 298
Open House Discount Contracts 2024-14
Open House Discount Contracts 2025-06
Completion Of Non-Exclusive Discount Agreements According To Section 130A (8) Sgb V On The Active Ingredients Mentioned With A Final Option In The Context Of The So-Called Open House Process.
Completion Not Excl. Pharmaceutical Discount Club. According To Section 130A (8) Sgb V By An Open House Model To The Active Ingredient Fusidic Acid/Betamethasone (Atc Code According To Who: D07Cc01)
Delivery Of Mhk Panels, Consumables And Cations Of Adjusted Müller-Hinton-Bouillon
Completion Not Excl. Pharmaceutical Discount Club. According To Section 130A (8) Sgb V By An Open House Model To The Active Ingredient Fusidic Acid/Betamethasone (Atc Code According To Who: D07Cc01)
Delivery Of Mhk Panels, Consumables And Cations Of Adjusted Müller-Hinton-Bouillon
1/Dlii6/Pm011 - Medicines Disinfection
Completion Of A Non -Exclusive Discount Agreement According To § 130A Paragraph 8 Sgb V On The Active Ingredient Vedolizumab, Atc L04Ag05 For The Period 01.07.2025 - 30.06.2027
Tenders by Country